Tesamorelin 5 mg

Dragon Pharma Tesamorelin 5 mg – GHRH Analogue for GH & Visceral Fat Research

Dragon Pharma Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), specifically the full-length biologically active 1-44 amino acid sequence of endogenous GHRH. It acts as a potent agonist at the GHRH receptor, stimulating the pituitary gland to release endogenous growth hormone in a pulsatile manner. Tesamorelin is distinguished from shorter GHRH analogues (like Sermorelin, GHRH 1-29) by its full-length structure, which may offer distinct pharmacokinetic properties in research models.

If you're looking for legit Tesamorelin for research purposes, this peptide has gained significant attention for its effects on GH pulsatility and, notably, its researched effects on visceral adipose tissue. For researchers studying the GH/IGF-1 axis, metabolic health, or body composition, Tesamorelin provides a well-characterized GHRH analogue with a robust research literature.

Why Athletes & Bodybuilders Are Researching Tesamorelin

Body composition and metabolic health are central to athletic performance. Tesamorelin research explores its ability to stimulate endogenous GH pulsatility, which may influence recovery, protein synthesis, and lipolysis. Notably, Tesamorelin has been extensively studied for its effects on visceral adipose tissue — the metabolically active fat around internal organs. For researchers studying GH secretion, body composition, or metabolic health, Tesamorelin offers a full-length GHRH analogue distinct from shorter fragments.

What Makes Dragon Pharma Tesamorelin Different?

• ✔ Full-length GHRH (1-44) analogue — complete endogenous sequence
• ✔ Stimulates pulsatile GH release — mimics natural secretion patterns
• ✔ Extensively researched for visceral adipose tissue effects
• ✔ Distinct pharmacokinetic profile from shorter GHRH analogues

Note for researchers: Tesamorelin is the full-length GHRH (1-44) analogue, distinct from shorter fragments like Sermorelin (1-29). For best results in your research, follow established protocols and always source Tesamorelin from verified suppliers like Dragon Pharma.

Product Specifications

Dosage, Reconstitution & Research Guidelines

Reconstitution Instructions (5 mg Vial)

Tesamorelin comes as a lyophilized powder in a 2 mL sterile vial. You'll need bacteriostatic water to reconstitute it properly.

• ✔ Add 2 mL of bacteriostatic water to the vial
• ✔ Final concentration: 2.5 mg per mL (2500 mcg/mL)
• ✔ Gently swirl — do not shake
• ✔ Refrigerate after reconstitution and use within 14 days

Need bacteriostatic water for your research? Get it here →

Typical Research Dosing

Based on available research literature, typical Tesamorelin dosing in animal studies falls in this range:

• ✔ 0.1 – 1.0 mg per kg in research models (dose-dependent GH release)
• ✔ Typical research dose: 0.5 – 2.0 mg per injection
• ✔ One 5 mg vial provides approximately 2.5-10 research doses depending on dose
• ✔ Dosing frequency typically once daily in GH research protocols

Insulin Syringe Dosing Guide

Using a standard 1 mL (100 unit) insulin syringe with Tesamorelin reconstituted to 2.5 mg/mL (2500 mcg/mL):

• ✔ 0.10 mL (10 units) = 250 mcg (0.25 mg)
• ✔ 0.20 mL (20 units) = 500 mcg (0.5 mg)
• ✔ 0.40 mL (40 units) = 1000 mcg (1.0 mg)
• ✔ 0.60 mL (60 units) = 1500 mcg (1.5 mg)
• ✔ 0.80 mL (80 units) = 2000 mcg (2.0 mg)
• ✔ Administer subcutaneously — abdomen area

How Researchers Are Using Tesamorelin

Tesamorelin is a full-length GHRH analogue (1-44) distinct from shorter fragments. It is particularly noted in research literature for its effects on visceral adipose tissue, in addition to GH pulsatility.

Popular research stacks include:

• ✔ Tesamorelin + Ipamorelin — for synergistic GH release through GHRH + GHRP pathways. View Ipamorelin →
• ✔ Tesamorelin + Sermorelin — for comparative GHRH analogue research (full-length vs. fragment). View Sermorelin →
• ✔ Tesamorelin + Adipotide — for combined GH axis and targeted fat research. View Adipotide →

Research Protocol Example (4-8 Weeks)

• ✔ Weeks 1–8: Tesamorelin 0.5-2.0 mg daily subQ
• ✔ Weeks 1–8: Ipamorelin 200-300 mcg daily (optional stack for GHRP synergy)
• ✔ Post-cycle observation: 2-4 weeks off before next research phase

Important Considerations

• 🔬 Tesamorelin is the full-length GHRH (1-44) analogue — complete endogenous sequence
• 💧 Extensively researched for effects on visceral adipose tissue
• ⚠️ Longer half-life than Sermorelin (~2 hours vs ~10-15 minutes)
• 📦 Well-characterized in clinical research with robust literature
• 📦 Always source Tesamorelin from verified suppliers like Dragon Pharma

Lab Verification – Third-Party Testing (Coming Soon)

At Dragon Pharma, every batch of Tesamorelin is scheduled for independent third-party HPLC testing to verify purity, mass, and sterility. The report for the current batch is in progress and will be published here as soon as it's available.

What Will Be Tested?

Why Third-Party Testing Matters

With the rise of counterfeit research peptides, independent lab verification is the only way to confirm you're getting what you paid for. Tesamorelin should meet strict purity and mass standards. Dragon Pharma commits to full transparency — as soon as each batch is tested, the COA will appear here with:

• ✔ HPLC chromatogram (visible peak purity)
• ✔ Measured mass vs label claim (5 mg)
• ✔ Batch number for traceability
• ✔ Test date and lab accreditation

For more information on Tesamorelin research and GHRH biology, refer to this PubMed study on Tesamorelin and visceral fat.

Shipping & Product Authenticity

What to Expect

• ✔ Orders processed within 24–48 hours after payment confirmation
• ✔ USA Domestic shipping via USPS/UPS/FedEx — tracking included
• ✔ International tracking available (update frequency varies by destination)
• ✔ Cold-chain packaging not required for lyophilized peptide before reconstitution, but vials are shipped in protective padding

How to Verify You Have Legit Tesamorelin

Counterfeit research peptides are a real problem. Here's how to confirm you're getting authentic Dragon Pharma Tesamorelin:

• ✔ QR code verification — each box includes a unique QR code. Scan it to verify the batch on Dragon Pharma's official database
• ✔ Scratch-off serial number — reveals a one-time use code for online verification
• ✔ Batch traceability — match the batch number on the vial to our system (lab report coming soon)
• ✔ Original crimp seal — intact, sterile vial with Dragon Pharma labeling

For complete delivery details, tracking policy, international customs, and reshipment terms, please see our Shipping Info page.

Storage Guidelines

Before Reconstitution (Lyophilized Powder)

• ✔ Store at 2–8°C (36–46°F) — standard refrigerator temperature
• ✔ Do not freeze the lyophilized powder
• ✔ Keep in original packaging, away from light
• ✔ Stable for up to 12 months when refrigerated properly
• ✔ Avoid repeated temperature changes (don't take in and out of fridge unnecessarily)

After Reconstitution (Mixed with Bacteriostatic Water)

• ✔ Store at 2–8°C (36–46°F)
• ✔ Use within 14 days of reconstitution
• ✔ Do not freeze after reconstitution — freezing can damage peptide structure
• ✔ Keep vial upright and sealed between uses
• ✔ Avoid direct light exposure

What to Avoid

• ❌ Freezing (before or after reconstitution — damages peptide bonds)
• ❌ Leaving at room temperature for extended periods (>24 hours)
• ❌ Shaking the vial — swirl gently instead
• ❌ Using cloudy or particulated solution after reconstitution
• ❌ Storing in bathroom or near heat sources

Inspection Before Use

Before using in your research, always inspect the vial:

• ✔ Lyophilized powder should appear as a white, intact cake or powder — not yellow, clumped, or melted
• ✔ After reconstitution, solution should be clear and particle-free
• ✔ Crimp seal must be intact — do not use if seal is broken or missing
• ✔ Check batch number and QR code for authenticity before use

Keep out of reach of children and unauthorized personnel. Follow institutional laboratory safety guidelines for handling research peptides.

Frequently Asked Questions